NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 19 2024
0mins
Source: Newsfilter
Analyst Views on G
Wall Street analysts forecast G stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for G is 50.00 USD with a low forecast of 43.00 USD and a high forecast of 55.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
3 Buy
3 Hold
0 Sell
Moderate Buy
Current: 46.220
Low
43.00
Averages
50.00
High
55.00
Current: 46.220
Low
43.00
Averages
50.00
High
55.00
About G
Genpact Limited is an agentic and advanced technology solutions company. The Company leverages process intelligence and artificial intelligence to deliver measurable outcomes. The Company's segments include Financial Services, Consumer and Healthcare, and High Tech and Manufacturing. Its Financial Services segment covers services the Company provides to clients in the banking, capital markets and insurance sectors. Its core operations services for these clients include customer onboarding, customer service, collections, and others. Its Consumer and Healthcare segment covers services it provides to clients in the consumer goods, retail, life sciences and healthcare sectors. The core operations services it provides to these clients include demand generation, sensing and planning, supply chain planning and management, and others. The Company's High Tech and Manufacturing segment covers services it provides to clients in the high-tech hardware, high-tech software and manufacturing sectors.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





